As large pharmaceutical companies increase their focus on orphan and specialty drugs, they are also seeking ways to reduce operating expenses and ...

The value-based healthcare model is pushing life science companies towards precision medicine, which requires extensive data analysis, technology integration and ...

As the global population grows increasingly focused on quality of life, many are also taking an active role in monitoring ...

To explore our 2015 Life Sciences Trends Report, download the PDF here or view an abbreviated overview below. In 2015, ...

The wholesale industry continues to transform, and companies focused on life sciences will face unique challenges in 2015. As specialty ...

Over the past decade, generics companies have saved the US healthcare system over $1 trillion. Globally, generics companies continue to reduce the ...

Healthcare reforms, shifting market demands, and increasing regulatory pressures are transforming the life sciences industry on a global scale. Patients, ...

The generic pharmaceutical industry remains one of the most entrepreneurial and dynamic facets of the healthcare system. According to IMS ...

The pharmaceutical industry is undergoing dramatic change. Pricing pressures, pipeline challenges, and emerging global markets are reshaping the way these ...

Regulatory pressures are adding layers of complexity to business decisions, pharma companies are increasingly leaning on biotechs to supplement their ...

In today’s rapidly changing business climate, understanding the regulatory and demographic environment of the medical device industry is only part of the ...

In this 2013 Life Sciences Trends Report, we understand it is important to know who you are, define the strategy, ...